logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 4
  • 1
    Balfour, Robert Henry, Dr
    Born in May 1980
    Individual (4 offsprings)
    Officer
    2023-05-24 ~ now
    OF - Director → CIF 0
  • 2
    Goldsmith, Bruce Aoki
    Born in December 1965
    Individual (1 offspring)
    Officer
    2025-02-03 ~ now
    OF - Director → CIF 0
  • 3
    Safarian, Alek
    Born in October 1964
    Individual (7 offsprings)
    Officer
    2023-03-08 ~ now
    OF - Director → CIF 0
    Mr Alek Safarian
    Born in October 1964
    Individual (7 offsprings)
    Person with significant control
    2023-03-08 ~ now
    PE - Ownership of shares – More than 50% but less than 75%CIF 0
    PE - Right to appoint or remove directorsCIF 0
    PE - Ownership of voting rights - More than 50% but less than 75%CIF 0
  • 4
    33, L-1855, 33 Avenue J F Kennedy, Luxembourg - Kirchberg, Luxembourg
    Corporate (2 offsprings)
    Person with significant control
    2023-05-12 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
parent relation
Company in focus

AXOVIA THERAPEUTICS LTD

Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Fixed Assets
644,613 GBP2024-12-31
644,613 GBP2023-12-31
Current Assets
5,019,920 GBP2024-12-31
1,257,932 GBP2023-12-31
Creditors
Amounts falling due within one year
-129,572 GBP2024-12-31
-102,804 GBP2023-12-31
Net Current Assets/Liabilities
4,903,212 GBP2024-12-31
1,163,698 GBP2023-12-31
Total Assets Less Current Liabilities
5,547,825 GBP2024-12-31
1,808,311 GBP2023-12-31
Creditors
Amounts falling due after one year
-5,100,000 GBP2024-12-31
Net Assets/Liabilities
271,023 GBP2024-12-31
1,751,946 GBP2023-12-31
Equity
271,023 GBP2024-12-31
1,751,946 GBP2023-12-31
Average Number of Employees
82024-01-01 ~ 2024-12-31
22023-03-08 ~ 2023-12-31

  • AXOVIA THERAPEUTICS LTD
    Info
    Registered number 14715294
    78 Pall Mall, London SW1Y 5ES
    PRIVATE LIMITED COMPANY incorporated on 2023-03-08 (2 years 11 months). The company status is Active.
    The last date of confirmation statement was made at 2025-03-07
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 12 November 2025 and licensed under the Open Government Licence v3.0.